Spanish national registry of celiac disease: incidence and clinical presentation.

J Pediatr Gastroenterol Nutr

*Hospital Severo Ochoa †Hospital Universitario Puerta de Hierro-Majadahonda, Madrid ‡Hospital Virgen del Camino, Pamplona §Hospital Universitario y Politécnico La Fe, Valencia ||Complejo Hospitalario Xeral-Cies, Vigo ¶Hospital Niños de Barcelona, Barcelona #Hospital San Pedro de Alcántara, Cáceres **Hospital Universitario Niño Jesús, Madrid ††Hospital Marqués de Valdecilla, Santander ‡‡Hospital Clínico Universitario de Santiago de Compostela, A Coruña §§Hospital de Torrecárdenas, Almería ||||Hospital Universitario Virgen de la Candelaria, Tenerife ¶¶Hospital de Fuenlabrada, Madrid ##Complejo Hospitalario Universitario de Albacete, Albacete ***Hospital Virgen del Rocío, Sevilla †††Hospital Universitario Sant Joan de Reus, Tarragona ‡‡‡Hospital Materno-Infantil, Las Palmas §§§Hospital Txagorritxu, Vitoria ||||||||||Hospital General de Móstoles, Madrid ¶¶¶Hospital Clínico Universitario de Valladolid, Valladolid ###Hospital Clínico Universitario de Salamanca, Salamanca ****Hospital Universitario de Canarias, Tenerife ††††Hospital Doce de Octubre, Madrid ‡‡‡‡Hospital Universitario de San Juan, Alicante §§§§Hospital Universitario Central de Asturias, Asturias, Spain.

Published: October 2014

Objectives: The aim of this study was to assess the incidence and clinical pattern of celiac disease (CD) presently diagnosed in Spanish children.

Methods: A prospective, multicenter, nationwide registry of new cases of CD in children <15 years was conducted from June 1, 2006 to May 31, 2007. The parameters studied were age at diagnosis, sex, clinical symptoms, associated diseases, nutritional status, CD serology, histological lesions, and HLA-DQ2/-DQ8. The crude incidence rate of CD was calculated as new cases per 1000 live births and as new cases per 100,000 person-years <15 years of age.

Results: A total of 974 new cases of CD were included. The median age at diagnosis was 2.3 years; 39.5% of CD diagnoses occurred in the first 2 years, 42% between 2 and 6, and 18.4% from 6 to 15. Total number of cases in each age group was 385, 409, and 180, respectively. Regarding clinical presentation 70.9% showed classical symptoms, 21.9% were nonclassical, and 7% were asymptomatic. A total of 95.7% of 931, 94.7% of 611, and 86.7% of 651 children tested positive, respectively, for immunoglobulin A (IgA) anti-transglutaminase type 2 antibodies, IgA endomysial antibodies, and IgA anti-gliadin antibodies. Villous atrophy was observed in 92.4% and increased intraepithelial lymphocytes with crypt hyperplasia in 3.3%. Of the children, 55% had normal growth, and 3.4% were overweight. The HLA phenotype was DQ2: 88.3%, DQ2/DQ8: 8.4%, and DQ8: 2.3%. The incidence rate was 7.9 cases of CD per 1000 live births and 54 cases per 100,000 person-years.

Conclusions: In Spain, the most frequent clinical presentation of CD is the classical form, mainly diagnosed during the first 2 years of life. The observed incidence of CD in Spanish children is much higher than the present CD incidence rates observed in other European countries.

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPG.0000000000000446DOI Listing

Publication Analysis

Top Keywords

celiac disease
8
incidence clinical
8
spanish national
4
national registry
4
registry celiac
4
disease incidence
4
clinical presentation
4
presentation objectives
4
objectives aim
4
aim study
4

Similar Publications

Interpreting positive celiac serology in children with new-onset type 1 diabetes.

J Pediatr Endocrinol Metab

January 2025

Division of Gastroenterology, Hepatology, & Nutrition, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.

Objectives: The association of celiac disease (CD) in type 1 diabetes mellitus (T1DM) is well-established, yet variation exists in screening practices. This study measures the accuracy of early screening with tissue transglutaminase Immunoglobulin A (TTG-IgA) and endomysial antibody (EMA) in newly diagnosed T1DM.

Methods: This is a retrospective study of children with T1DM between 2013 and 2019 with early CD screening and follow-up.

View Article and Find Full Text PDF

Background: In uncertain cases of coeliac disease (CD), gluten challenge (GC) may be necessary to confirm or exclude the diagnosis. However, data on diagnostic outcomes after GC are limited.

Aims: We aimed to evaluate outcomes after GC in patients with unconfirmed CD who had already started a gluten-free diet (GFD), and identify predictors of a confirmed diagnosis.

View Article and Find Full Text PDF

The correlation between clinical, serological, and endoscopic findings and histological response after a gluten-free diet (GFD) is limited in adult celiac (CD) patients. This study aims to evaluate the effects of GFD on intraepithelial lymphocyte (IEL) localization by comparing the histopathological, clinical, serological, and endoscopic findings of adult CD patients. The patients (n = 131) were divided into three groups: those with good (CDgc) (n = 23) and poor (CDpc) (n = 21) GFD compliance and newly diagnosed ones (nCD) (n = 87).

View Article and Find Full Text PDF

Interleukin 6 (IL6) is an inflammatory biomarker linked to central and peripheral nervous system diseases. This study combined bioinformatics and statistical meta-analysis to explore potential associations between IL6 gene variants (rs1800795, rs1800796, and rs1800797) and neurological disorders (NDs) and brain cancer. The meta-analysis was conducted on substantial case-control datasets and revealed a significant correlation between IL6 SNPs (rs1800795 and rs1800796) with overall NDs (p-value < 0.

View Article and Find Full Text PDF

Autoimmune enteropathy (AIE) is a rare immune mediated disorder primarily affecting children, characterized by chronic diarrhea, malabsorption, vomiting, weight loss and villous atrophy. It has also been observed in adults presenting diagnostic and treatment challenges due to its overlap with other gastrointestinal disorders such as celiac disease. Initial diagnostic criteria for AIE include small bowel villous atrophy, lack of response to dietary restrictions, presence of anti-enterocyte antibodies, and predisposition to autoimmunity without severe immunodeficiency.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!